GlassScriptPhysician profile
Angela P Lambert
NPI 1659674711
$526.47
in general payments reported to CMS, 2019-2025
11 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $41.33 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $117.65 | 2025 | Airsupra, Nexium |
| Otsuka America Pharmaceutical, INC. | $100.20 | 2024-2025 | Rexulti |
| Pfizer INC. | $70.63 | 2025 | |
| Viiv Healthcare Company | $67.11 | 2025 | Apretude |
| Lilly USA, LLC | $44.98 | 2025 | Kisunla, Mounjaro, Zepbound |
| Seqirus USA INC | $26.64 | 2025 | Flucelvax |
| Exact Sciences Corporation | $25.32 | 2025 | The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $20.62 | 2025 | Slynd |
| Merck Sharp & Dohme LLC | $19.94 | 2025 | Gardasil 9, Vaqta, Capvaxive |
| Novo Nordisk INC | $17.57 | 2025 | Wegovy |
| Glaxosmithkline, LLC. | $15.81 | 2024 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.